478 related articles for article (PubMed ID: 15339200)
1. Central precocious puberty: current treatment options.
Antoniazzi F; Zamboni G
Paediatr Drugs; 2004; 6(4):211-31. PubMed ID: 15339200
[TBL] [Abstract][Full Text] [Related]
2. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. The German-Dutch Precocious Puberty Study Group.
Partsch CJ; Hümmelink R; Peter M; Sippell WG; Oostdijk W; Odink RJ; Drop SL
Horm Res; 1993; 39(3-4):111-7. PubMed ID: 8262471
[TBL] [Abstract][Full Text] [Related]
3. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.
Bertelloni S; Baroncelli GI; Sorrentino MC; Perri G; Saggese G
Eur J Pediatr; 1998 May; 157(5):363-7. PubMed ID: 9625331
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of central precocious puberty--can final height be improved? German/Dutch Central Precocious Puberty Study Group.
Sippell WG
Horm Res; 1994; 41 Suppl 2():14-5. PubMed ID: 8088698
[TBL] [Abstract][Full Text] [Related]
5. [Comparison between complete and incomplete suppression of the hypophyseal-gonadal axis in girls with central precocious puberty: effect on growth and prospective final height].
Partsch CJ; Hümmelink R; Sippell WG; Oostdijk W; Odink RJ; Drop SL
Monatsschr Kinderheilkd; 1993 Dec; 141(12):935-9. PubMed ID: 8114776
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone analog therapy for central precocious puberty and other childhood disorders affecting growth and puberty.
Lee PA; Houk CP
Treat Endocrinol; 2006; 5(5):287-96. PubMed ID: 17002488
[TBL] [Abstract][Full Text] [Related]
7. Luteinizing hormone (LH) and estradiol suppression and growth in girls with central precocious puberty: is more suppression better? Are pre-injection LH levels useful in monitoring treatment?
Kunz GJ; Sherman TI; Klein KO
J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1189-98. PubMed ID: 18183790
[TBL] [Abstract][Full Text] [Related]
8. Precocious puberty and statural growth.
Carel JC; Lahlou N; Roger M; Chaussain JL
Hum Reprod Update; 2004; 10(2):135-47. PubMed ID: 15073143
[TBL] [Abstract][Full Text] [Related]
9. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
[TBL] [Abstract][Full Text] [Related]
10. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
Lazar L; Pertzelan A; Weintrob N; Phillip M; Kauli R
J Clin Endocrinol Metab; 2001 Sep; 86(9):4127-32. PubMed ID: 11549638
[TBL] [Abstract][Full Text] [Related]
11. Final adult height in "early normal pubertal girls" treated with gonadotropin releasing hormone agonists.
Wacharasindhu S; Srivuthana S; Aroonparkmongkol S; Supornsilchai V; Hiranrat P; Yodvisitsak V
J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S170-3. PubMed ID: 12929985
[TBL] [Abstract][Full Text] [Related]
12. Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues.
Bertelloni S; Baroncelli GI; Ferdeghini M; Menchini-Fabris F; Saggese G
Eur J Pediatr; 2000 May; 159(5):369-74. PubMed ID: 10834524
[TBL] [Abstract][Full Text] [Related]
13. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone agonists in the treatment of girls with central precocious puberty.
Breyer P; Haider A; Pescovitz OH
Clin Obstet Gynecol; 1993 Sep; 36(3):764-72. PubMed ID: 8403623
[TBL] [Abstract][Full Text] [Related]
15. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
[TBL] [Abstract][Full Text] [Related]
16. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
Léger J; Reynaud R; Czernichow P
J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis.
Li P; Li Y; Yang CL
Medicine (Baltimore); 2014 Dec; 93(27):e260. PubMed ID: 25501098
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone analogue treatment for precocious puberty. Twenty years of experience.
Heger S; Sippell WG; Partsch CJ
Endocr Dev; 2005; 8():94-125. PubMed ID: 15722620
[TBL] [Abstract][Full Text] [Related]
19. Serum inhibin A and inhibin B in central precocious puberty before and during treatment with GnRH agonists.
Sehested A; Andersson AM; Müller J; Skakkebaek NE
Horm Res; 2000; 54(2):84-91. PubMed ID: 11251372
[TBL] [Abstract][Full Text] [Related]
20. Treatment of central precocious puberty by GnRH analogs: long-term outcome in men.
Bertelloni S; Mul D
Asian J Androl; 2008 Jul; 10(4):525-34. PubMed ID: 18478155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]